Developmental plasticity of stem cells and diseases

Medical Hypotheses

Volumn 75, Issue 6, 2010, Pages 507-510

  Luo, Guopei ^a   Long, Jiang ^a   Zhang, Bo ^a   Liu, Chen ^a   Xu, Jin ^a   Yu, Xianjun ^a   Ni, Quanxing ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL RENEWAL; CHRONIC DISEASE; FETAL STEM CELL; GENOMIC INSTABILITY; HUMAN; MULTIPOTENT STEM CELL; MUTATION; NUTRITIONAL DEFICIENCY; PHENOTYPIC PLASTICITY; PRENATAL PERIOD;

CELL DIFFERENTIATION; CHRONIC DISEASE; HUMANS; MODELS, BIOLOGICAL; MULTIPOTENT STEM CELLS; MUTATION; NEOPLASMS;

EID: 77958474224     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.07.007     Document Type: Article

References (54)

1. Rossi D.J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., Weissman I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447:725-729.
2. Rossi D.J., Jamieson C.H., Weissman I.L. Stems cells and the pathways to aging and cancer. Cell 2008, 132:681-696.
3. Park Y., Gerson S.L. DNA repair defects in stem cell function and aging. Ann Rev Med 2005, 56:495-508.
4. Martens D.J., Tropepe V., van Der Kooy D. Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor-responsive neural stem cells within the embryonic forebrain germinal zone. J Neurosci 2000, 20:1085-1095.
5. Kimber S.J. Molecular interactions at the maternal-embryonic interface during the early phase of implantation. Semin Reprod Med 2000, 18:237-253.
6. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000, 18:399-404.
7. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
8. Zwaka T.P., Thomson J.A. A germ cell origin of embryonic stem cells?. Development 2005, 132:227-233.
9. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
10. Slack J.M. Origin of stem cells in organogenesis. Science 2008, 322:1498-1501.
11. Bryder D., Rossi D.J., Weissman I.L. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 2006, 169:338-346.
12. Heijmans B.T., Tobi E.W., Stein A.D., Putter H., Blauw G.J., Susser E.S., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008, 105:17046-17049.
13. Taylor R.W., Barron M.J., Borthwick G.M., Gospel A., Chinnery P.F., Samuels D.C., et al. Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest 2003, 112:1351-1360.
14. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008, 359:61-73.
15. Nijnik A., Woodbine L., Marchetti C., Dawson S., Lambe T., Liu C., et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007, 447:686-690.
16. Bateson P., Barker D., Clutton-Brock T., Deb D., D'Udine B., Foley R.A., et al. Developmental plasticity and human health. Nature 2004, 430:419-421.
17. Gillman M.W. Developmental origins of health and disease. N Engl J Med 2005, 353:1848-1850.
18. Stothard K.J., Tennant P.W., Bell R., Rankin J. Maternal overweight and obesity and the risk of congenital anomalies: a systematic review and meta-analysis. JAMA 2009, 301:636-650.
19. Barker D.J., Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1:1077-1081.
20. Barker D.J., Osmond C., Forsen T.J., Kajantie E., Eriksson J.G. Trajectories of growth among children who have coronary events as adults. N Engl J Med 2005, 353:1802-1809.
21. Bhargava S.K., Sachdev H.S., Fall C.H., Osmond C., Lakshmy R., Barker D.J., et al. Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood. N Engl J Med 2004, 350:865-875.
22. Cooper C., Fall C., Egger P., Hobbs R., Eastell R., Barker D. Growth in infancy and bone mass in later life. Ann Rheum Dis 1997, 56:17-21.
23. Hales C.N., Barker D.J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992, 35:595-601.
24. Kensara O.A., Wootton S.A., Phillips D.I., Patel M., Jackson A.A., Elia M. Fetal programming of body composition: relation between birth weight and body composition measured with dual-energy X-ray absorptiometry and anthropometric methods in older Englishmen. Am J Clin Nutr 2005, 82:980-987.
25. Osmond C., Barker D.J., Winter P.D., Fall C.H., Simmonds S.J. Early growth and death from cardiovascular disease in women. BMJ 1993, 307:1519-1524.
26. Frankel S., Elwood P., Sweetnam P., Yarnell J., Smith G.D. Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet 1996, 348:1478-1480.
27. Barker D.J., Forsen T., Uutela A., Osmond C., Eriksson J.G. Size at birth and resilience to effects of poor living conditions in adult life: longitudinal study. BMJ 2001, 323:1273-1276.
28. Doyle P., Beral V., Maconochie N. Preterm delivery, low birthweight and small-for-gestational-age in liveborn singleton babies resulting from in-vitro fertilization. Hum Reprod 1992, 7:425-428.
29. Schieve L.A., Meikle S.F., Ferre C., Peterson H.B., Jeng G., Wilcox L.S. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002, 346:731-737.
30. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988.
31. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737.
32. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
33. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
34. Hope K.J., Jin L., Dick J.E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 2004, 5:738-743.
35. Jordan C.T., Guzman M.L., Noble M. Cancer stem cells. N Engl J Med 2006, 355:1253-1261.
36. Rak J. Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis?. Med Hypotheses 2006, 66:601-604.
37. Wang J.C., Dick J.E. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005, 15:494-501.
38. Pardal R., Clarke M.F., Morrison S.J. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902.
39. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
40. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
41. Taipale J., Beachy P.A. The Hedgehog and Wnt signalling pathways in cancer. Nature 2001, 411:349-354.
42. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2008.
43. Ahlgren M., Melbye M., Wohlfahrt J., Sorensen T.I. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004, 351:1619-1626.
44. Ahlgren M., Wohlfahrt J., Olsen L.W., Sorensen T.I., Melbye M. Birth weight and risk of cancer. Cancer 2007, 110:412-419.
45. Michos A., Xue F., Michels K.B. Birth weight and the risk of testicular cancer: a meta-analysis. Int J Cancer 2007, 121:1123-1131.
46. Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004, 432:324-331.
47. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003, 17:3029-3035.
48. Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004, 6:587-596.
49. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004, 351:657-667.
50. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 2006, 442:818-822.
51. Radtke F., Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307:1904-1909.
52. Hammond S.M., Sharpless N.E. HMGA2, microRNAs, and stem cell aging. Cell 2008, 135:1013-1016.
53. Sharpless N.E., DePinho R.A. How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 2007, 8:703-713.
54. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002, 52:23-47.